Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin
written by admin

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

0 comment
0
FacebookTwitterPinterestEmail

Related Posts

Outstanding Antimony Results at Casablanca

High-Grade Antimony Assays Confirm Surface Continuity at DAM

Vale CEO: Real Assets Gaining Traction as Money...

Valeura Energy Inc. Announces Thailand to Prioritise Domestic...

Bold Ventures Signs Agreement to Acquire 6 Key...

Closing date for director nominations

New Found Gold Grade Control Drilling Continues to...

Allied Critical Metals Delivers Robust Initial PEA at...

Bold Ventures Provides Update on Burchell Drilling Progress...

Crypto Market Update: Bitcoin Price Retreats Again After...

Leave a Comment

Save my name, email, and website in this browser for the next time I comment.